118 related articles for article (PubMed ID: 10848789)
41. Phenotypic conversion from t(8;21) acute myeloid leukemia to MLL gene rearrangement-positive acute lymphoblastic leukemia.
Ohsaka A; Kato K; Hikiji K
Hematopathol Mol Hematol; 1998; 11(3-4):185-92. PubMed ID: 9844825
[TBL] [Abstract][Full Text] [Related]
42. MLL partial tandem duplications in acute leukemia cell lines.
Quentmeier H; Reinhardt J; Zaborski M; Drexler HG
Leukemia; 2003 May; 17(5):980-1. PubMed ID: 12750714
[No Abstract] [Full Text] [Related]
43. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
[TBL] [Abstract][Full Text] [Related]
44. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies.
Zhang Y; Poetsch M; Weber-Matthiesen K; Rohde K; Winkemann M; Haferlach T; Gassmann W; Ludwig WD; Grote W; Löffler H; Schlegelberger B
Br J Haematol; 1996 Mar; 92(3):673-80. PubMed ID: 8616034
[TBL] [Abstract][Full Text] [Related]
45. Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia.
Casale F; Addeo R; D'Angelo V; Indolfi P; Poggi V; Morgera C; Crisci S; Di Tullio MT
Int J Oncol; 2003 Jan; 22(1):123-8. PubMed ID: 12469194
[TBL] [Abstract][Full Text] [Related]
46. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
Ramakers-van Woerden NL; Beverloo HB; Veerman AJ; Camitta BM; Loonen AH; van Wering ER; Slater RM; Harbott J; den Boer ML; Ludwig WD; Haas OA; Janka-Schaub GE; Pieters R
Leukemia; 2004 Mar; 18(3):521-9. PubMed ID: 14712291
[TBL] [Abstract][Full Text] [Related]
47. Discordant clinical presentation and outcome in infant twins sharing a common clonal leukaemia.
Campbell M; Cabrera ME; Legues ME; Ridge S; Greaves M
Br J Haematol; 1996 Apr; 93(1):166-9. PubMed ID: 8611455
[TBL] [Abstract][Full Text] [Related]
48. Myeloperoxidase gene expression in non-infant pro-B acute lymphoblastic leukaemia with or without ALL1/AF4 transcript.
Serrano J; Lo Coco F; Sprovieri T; Elia L; Vitale A; Gregorj C; Tafuri A; Sánchez J; Román J; Torres A; Cimino G
Br J Haematol; 2000 Dec; 111(4):1065-70. PubMed ID: 11167741
[TBL] [Abstract][Full Text] [Related]
49. Pseudo-rearrangement of the MLL gene at chromosome 11q23: a cautionary note on genotype analysis of leukaemia patients.
Stanulla M; Schünemann HJ; Thandla S; Brecher ML; Aplan PD
Mol Pathol; 1998 Apr; 51(2):85-9. PubMed ID: 9713591
[TBL] [Abstract][Full Text] [Related]
50. Clinical relevance of residual disease monitoring by polymerase chain reaction in patients with ALL-1/AF-4 positive-acute lymphoblastic leukaemia.
Cimino G; Elia L; Rivolta A; Rapanotti MC; Rossi V; Alimena G; Annino L; Canaani E; Lo Coco F; Biondi A
Br J Haematol; 1996 Mar; 92(3):659-64. PubMed ID: 8616032
[TBL] [Abstract][Full Text] [Related]
51. Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research.
Reichel M; Gillert E; Breitenlohner I; Repp R; Greil J; Beck JD; Fey GH; Marschalek R
Cancer Res; 1999 Jul; 59(14):3357-62. PubMed ID: 10416593
[TBL] [Abstract][Full Text] [Related]
52. BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.
Pocock CF; Malone M; Booth M; Evans M; Morgan G; Greil J; Cotter FE
Br J Haematol; 1995 Aug; 90(4):855-67. PubMed ID: 7669664
[TBL] [Abstract][Full Text] [Related]
53. Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements.
Tsutsumi S; Taketani T; Nishimura K; Ge X; Taki T; Sugita K; Ishii E; Hanada R; Ohki M; Aburatani H; Hayashi Y
Cancer Res; 2003 Aug; 63(16):4882-7. PubMed ID: 12941810
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of the Ikaros 6 isoform is restricted to t(4;11) acute lymphoblastic leukaemia in children and infants and has a role in B-cell survival.
Ruiz A; Jiang J; Kempski H; Brady HJ
Br J Haematol; 2004 Apr; 125(1):31-7. PubMed ID: 15015965
[TBL] [Abstract][Full Text] [Related]
55. Detection of MLL gene self-fusions by RT-PCR and automated fluorescent DNA-fragment analysis.
Forrest DL; Adomat SA; Nevill TJ; Barnett MJ; Growe G; Horsman DE
Cancer Genet Cytogenet; 1999 Jul; 112(2):181-3. PubMed ID: 10686950
[No Abstract] [Full Text] [Related]
56. Translocation (10;11)(p13;p15) in an infant acute myeloid leukemia with MLL gene rearrangement.
Marco F; Bureo E; Delgado MD; Richard C; Cuadrado MA; Pérez Retortillo JA; Recio M; Zubizarreta A
Cancer Genet Cytogenet; 1999 Oct; 114(1):68-70. PubMed ID: 10526538
[TBL] [Abstract][Full Text] [Related]
57. Novel leukaemia markers.
Micklem KJ
Biosci Rep; 1995 Dec; 15(6):463-8. PubMed ID: 9156576
[TBL] [Abstract][Full Text] [Related]
58. Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.
Tsurusawa M; Saeki K; Katano N; Fujimoto T
Pediatr Hematol Oncol; 1998; 15(2):143-55. PubMed ID: 9592841
[TBL] [Abstract][Full Text] [Related]
59. Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in children.
Pituch-Noworolska A; Hajto B; Balwierz W; Klus K
Haematologia (Budap); 2001; 31(3):191-207. PubMed ID: 11855781
[TBL] [Abstract][Full Text] [Related]
60. Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.
Robinson BW; Behling KC; Gupta M; Zhang AY; Moore JS; Bantly AD; Willman CL; Carroll AJ; Adamson PC; Barrett JS; Felix CA
Br J Haematol; 2008 Jun; 141(6):827-39. PubMed ID: 18422996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
